Restart Life Sciences reports $465,715 revenue after Holy Crap Foods acquisition

Verifying
  • Restart Life Sciences became a revenue-generating business after acquiring Holy Crap Foods.
  • $465,715 in revenue was reported for the first half of 2026.
  • Revenue increased 146% in Q2 2026 compared with Q1.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.